| Identification | Back Directory | [Name]
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide | [CAS]
1252927-47-1 | [Synonyms]
GSK-1071306
N-Demethyl Pazopanib
Pazopanib Impurity 41
Pazopanib Impurity 13
Pazopanib metabolite M27
Pazopanib metabolite M27 HCl
Pazopanib N-Desmethyl Impurity
Pazopanib metabolite M27 Hydrochloride
5-[[4-[(2,3-dimethylindazol-6-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methyl- | [Molecular Formula]
C20H21N7O2S | [MDL Number]
MFCD28130076 | [MOL File]
1252927-47-1.mol | [Molecular Weight]
423.491 |
| Chemical Properties | Back Directory | [Melting point ]
>252°C (dec.) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Ethyl Acetate (Slightly) | [form ]
Solid | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Uses]
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide is a Pazopanib (P210925) impurity. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. | [Uses]
N-demethyl Pazopanib is a Pazopanib (P210925) impurity. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|